GLPG
Galapagos N.V.
NASDAQ · Healthcare · Biotechnology · BE
$27.98
+1.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.26x
- PEG TTM
- —
- Price / book
- 0.49x
- Price / sales
- 1.52x
- Price / cash flow
- -5.36x
Enterprise value
- Enterprise value
- -$1.6B
- EV / sales
- -1.33x
- EV / EBITDA
- -6.74x
- EV / EBIT
- -3.55x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026